2024's Most Advanced Weight Loss Technology

The Future of
Weight Loss is Here

Introducing Retatrutide - the world's first triple-agonist medication achieving 24%+ weight loss. Now available exclusively in Nigeria.

24%

Average Weight Loss

Hormone Pathways

Most Effective GLP-1

Claim Your Early Access Explore the Science

Limited Availability - First 100 patients receive priority access

Next-Generation Science

What is Retatrutide?

The world's first and only triple-hormone agonist that targets three metabolic pathways simultaneously for unprecedented weight loss results.

GLP-1

Appetite Control

Reduces hunger signals and slows gastric emptying. The same mechanism as Ozempic and Wegovy.

GIP

Fat Metabolism

Enhances fat burning and improves insulin sensitivity. Combined with GLP-1 in Tirzepatide/Mounjaro.

Glucagon

Energy Expenditure

EXCLUSIVE TO RETATRUTIDE - Increases calorie burn and mobilizes stored fat for energy.

While other medications target one or two pathways, Retatrutide activates all three - delivering weight loss results never before possible with any single medication.

Clinical Evidence

Why Retatrutide is Different

Head-to-head comparison based on clinical trial data. The numbers speak for themselves.

Retatrutide NEW

24.2%

Triple agonist (GLP-1 + GIP + Glucagon)

Tirzepatide (Mounjaro/Zepbound)

22.5%

Dual agonist (GLP-1 + GIP)

Semaglutide (Ozempic/Wegovy)

15.2%

Single agonist (GLP-1 only)

+60%

More effective than Semaglutide

+8%

More than Tirzepatide

Weekly

Single injection

48 Weeks

Clinical trial duration

Limited Availability

Get Early Access

As a cutting-edge treatment, Retatrutide availability is limited. Secure your spot in the first cohort of Nigerian patients.

Verified Authenticity

Every vial comes with batch verification and cold-chain certification. 100% authentic compounded medication.

Doctor Supervised

Mandatory consultation with our medical team. Personalized dosing protocol and ongoing monitoring included.

Priority Support

Early access members receive dedicated WhatsApp support and priority for restocks and new dosage availability.

Be Among the First 100

Early adopters receive priority access and guaranteed supply for their first 3-month protocol.

Join Early Access via WhatsApp

Treatment Programs

Early Access Programs

As the newest and most advanced GLP-1 therapy, Retatrutide is positioned as a premium treatment for those seeking the absolute best results.

GETTING STARTED

Starter Protocol

First month - titration phase

4 weekly doses (starting dose)
Medical consultation included
Injection supplies provided
WhatsApp support access

Start Your Journey

MAXIMUM RESULTS

Maintenance Protocol

Full therapeutic dose

4 weekly doses (full strength)
Monthly check-in consultation
Priority restocking guarantee
VIP WhatsApp support
Cold-chain delivery included

Get Maximum Results

Contact us for pricing. Retatrutide is the newest, most advanced medication requiring specialized handling and limited global supply.

Phase 2 Trial Data

The Clinical Promise

Results from the landmark clinical trial that changed everything we know about medical weight loss.

1 Weight Loss Results

24.2% average body weight reduction at 48 weeks
100% of participants on highest dose lost >5% body weight
83% achieved >10% weight loss (clinically significant)
63% achieved >20% weight loss

2 Metabolic Improvements

Significant reduction in HbA1c (blood sugar marker)
Improved cholesterol profiles
Reduced blood pressure
Enhanced insulin sensitivity

Source: Jastreboff AM, et al. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity" - New England Journal of Medicine, 2023

Pioneer Program

Be Among the First in Nigeria

Early adopters don't just get a medication - they get to be part of a transformation. The same science that powers tomorrow's medicine, available today.

First

Triple agonist in Nigeria

100

Early access spots

24%

Potential weight loss

Claim Your Spot Now

Have Questions?

Frequently Asked Questions

Retatrutide is a triple agonist, meaning it activates three hormone receptors: GLP-1, GIP, and Glucagon. Ozempic (semaglutide) only activates GLP-1, while Mounjaro (tirzepatide) activates GLP-1 and GIP. The addition of Glucagon receptor activation in Retatrutide increases energy expenditure and fat metabolism, resulting in superior weight loss of 24%+ compared to 15% for Ozempic and 22% for Mounjaro.

Retatrutide has successfully completed Phase 2 clinical trials with excellent safety data, published in the New England Journal of Medicine. It is currently in Phase 3 trials for FDA approval. We provide compounded Retatrutide under physician supervision, following the same protocols used in clinical trials. All patients undergo medical screening before starting treatment.

The most common side effects are similar to other GLP-1 medications: mild nausea, decreased appetite, and occasional digestive discomfort. These typically resolve within the first few weeks as your body adjusts. Our gradual titration protocol (starting at lower doses) minimizes side effects. Serious side effects are rare but will be discussed during your medical consultation.

Retatrutide is a once-weekly subcutaneous injection, just like Ozempic and Mounjaro. We provide all injection supplies and detailed instructions. Most patients find self-injection easy after the first time. The injection is typically given in the abdomen, thigh, or upper arm.

Retatrutide is the newest and most advanced GLP-1 medication available. As a cutting-edge compound not yet widely manufactured, supply is limited and production costs are higher. Additionally, its superior efficacy (24% vs 15-22% weight loss) means faster results and potentially shorter treatment duration, offering better value long-term.

Simply click any WhatsApp button on this page to connect with our team. We'll schedule a consultation to review your medical history, discuss your goals, and determine if Retatrutide is right for you. If approved, your first month's supply can be delivered within 3-5 business days to anywhere in Nigeria with cold-chain preservation.

Yes! We deliver to all major cities in Nigeria including Lagos, Abuja, Port Harcourt, Kano, Ibadan, and more. All deliveries use temperature-controlled packaging to maintain medication integrity. Lagos deliveries are typically same-day or next-day; other locations within 2-4 business days.

The Future of Weight Loss is Here